MX2016001436A - Regeneracion de tejido dañado. - Google Patents

Regeneracion de tejido dañado.

Info

Publication number
MX2016001436A
MX2016001436A MX2016001436A MX2016001436A MX2016001436A MX 2016001436 A MX2016001436 A MX 2016001436A MX 2016001436 A MX2016001436 A MX 2016001436A MX 2016001436 A MX2016001436 A MX 2016001436A MX 2016001436 A MX2016001436 A MX 2016001436A
Authority
MX
Mexico
Prior art keywords
regeneration
wound
damaged tissue
tropoelastin
enabling
Prior art date
Application number
MX2016001436A
Other languages
English (en)
Inventor
Anthony Steven Weiss
Original Assignee
Elastagen Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013903092A external-priority patent/AU2013903092A0/en
Application filed by Elastagen Pty Ltd filed Critical Elastagen Pty Ltd
Publication of MX2016001436A publication Critical patent/MX2016001436A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0203—Adhesive bandages or dressings with fluid retention members
    • A61F13/0213—Adhesive bandages or dressings with fluid retention members the fluid retention member being a layer of hydrocolloid, gel forming material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633—Extracellular matrix [ECM]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

Un método de cicatrización para una herida que incluye contactar un borde de la herida una tropoelastina o un péptido derivado de la elastina en condiciones para permitir un contacto ininterrumpido de la tropoelastina con el borde de la herida durante un período de tiempo para permitir la re-epitelialización de la herida.
MX2016001436A 2013-08-13 2014-08-13 Regeneracion de tejido dañado. MX2016001436A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2013903092A AU2013903092A0 (en) 2013-08-13 Regeneration of damaged tissue
PCT/AU2014/050180 WO2015021508A1 (en) 2013-08-13 2014-08-13 Regeneration of damaged tissue

Publications (1)

Publication Number Publication Date
MX2016001436A true MX2016001436A (es) 2016-07-05

Family

ID=52467858

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2016001436A MX2016001436A (es) 2013-08-13 2014-08-13 Regeneracion de tejido dañado.
MX2020011880A MX2020011880A (es) 2013-08-13 2016-01-29 Regeneracion de tejido da?ado.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2020011880A MX2020011880A (es) 2013-08-13 2016-01-29 Regeneracion de tejido da?ado.

Country Status (12)

Country Link
US (3) US20160194379A1 (es)
EP (2) EP3033099B1 (es)
JP (3) JP6382311B2 (es)
KR (3) KR20230004965A (es)
CN (2) CN110464837A (es)
AU (3) AU2014306362B2 (es)
BR (1) BR112016003082A8 (es)
CA (1) CA2920312C (es)
ES (1) ES2965893T3 (es)
MX (2) MX2016001436A (es)
RU (1) RU2677637C2 (es)
WO (1) WO2015021508A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014063194A1 (en) 2012-10-23 2014-05-01 The University Of Sydney Elastic hydrogel
EP3821918A1 (en) 2012-12-10 2021-05-19 Allergan Pharmaceuticals International Limited Scalable three-dimensional elastic construct manufacturing
CN110464837A (zh) 2013-08-13 2019-11-19 爱力根制药国际有限公司 受损组织的再生
CN107921100A (zh) * 2015-09-01 2018-04-17 埃拉斯塔根私人有限公司 骨形成
US20190275204A1 (en) * 2016-11-04 2019-09-12 Elastagen Pty Ltd Biosynthetic devices
US20200345623A1 (en) * 2019-05-03 2020-11-05 Allergan Pharmaceuticals International Limited Methods of scar prevention and/or treatment
WO2022076117A1 (en) * 2020-09-08 2022-04-14 Protein Genomics Inc. Biomimetic wound healing devices and related methods of treating diabetic wounds

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675387A (en) 1985-07-26 1987-06-23 E. I. Du Pont De Nemours And Company Method for extracting protein with organic acid
US5260203A (en) 1986-09-02 1993-11-09 Enzon, Inc. Single polypeptide chain binding molecules
US4947840A (en) 1987-08-21 1990-08-14 Massachusetts Institute Of Technology Biodegradable templates for the regeneration of tissues
ES2052027T5 (es) 1988-11-11 2005-04-16 Medical Research Council Clonacion de secuencias de dominio variable de inmunoglobulina.
AU645794B2 (en) 1990-03-30 1994-01-27 Shiseido Company Ltd. Process for purifying polypeptide
DE69334287D1 (de) 1992-09-25 2009-07-09 Avipep Pty Ltd Zielmoleküle-bindende Polypeptide bestehend aus einer IG-artigen VL Domäne die an eine IG-artige VH Domäne gebunden ist
ATE412052T1 (de) 1992-12-22 2008-11-15 Univ Sydney Synthetische polynukleotide
US5726040A (en) 1993-11-10 1998-03-10 Ensley; Burt D. Cosmetic compositions including tropoelastin isomorphs
US7001328B1 (en) * 1994-11-15 2006-02-21 Kenton W. Gregory Method for using tropoelastin and for producing tropoelastin biomaterials
AUPO591797A0 (en) 1997-03-27 1997-04-24 Commonwealth Scientific And Industrial Research Organisation High avidity polyvalent and polyspecific reagents
US5969106A (en) 1996-08-07 1999-10-19 The Hospital For Sick Children Self-aligning peptides modeled on human elastin and other fibrous proteins
AUPO156596A0 (en) * 1996-08-09 1996-09-05 University Of Sydney, The Synthetic polynucleotides
AU737125B2 (en) 1997-02-07 2001-08-09 Kenton W. Gregory Method for using tropoelastin and for producing tropoelastin biomaterials
AUPO811797A0 (en) 1997-07-18 1997-08-14 University Of Sydney, The Tropoelastin derivatives
AU9313298A (en) 1997-09-04 1999-03-22 Point Biomedical Corporation Injectable tissue reconstruction material
AUPP472398A0 (en) 1998-07-17 1998-08-13 University Of Sydney, The Protease susceptibility II
US7465785B2 (en) 1999-03-08 2008-12-16 Genentech, Inc. Polypeptide encoded by a nucleic acid over-expressed in melanoma
CA2383539C (en) * 1999-05-28 2007-12-04 Kenton W. Gregory Methods for producing laminated elastin, elastin-based materials and tropoelastin products for repairing and/or replacing tissue
CA2685349C (en) 1999-11-15 2013-09-17 Bio Syntech Canada Inc. Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution
US20050244393A1 (en) 1999-12-22 2005-11-03 Henogen S.A. Sealant or tissue generating product
US6808707B2 (en) * 2000-02-04 2004-10-26 Matrix Design Wound healing compositions and methods using tropoelastin and lysyl oxidase
US20040110439A1 (en) 2001-04-20 2004-06-10 Chaikof Elliot L Native protein mimetic fibers, fiber networks and fabrics for medical use
WO2002096978A1 (fr) 2001-05-30 2002-12-05 Keiichi Miyamoto Elastine reticulee et son procede de production
AU2002952492A0 (en) 2002-11-06 2002-11-21 Cbio Limited Chaperonin 10 immunosuppression
US8038991B1 (en) 2003-04-15 2011-10-18 Abbott Cardiovascular Systems Inc. High-viscosity hyaluronic acid compositions to treat myocardial conditions
US8383158B2 (en) 2003-04-15 2013-02-26 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
FR2855969B1 (fr) 2003-06-13 2012-11-30 Coletica Stimulation de l'activite d'une isoforme de lysyl oxydase pour lutter contre certaines pathologies dues a une elastogenese incomplete, absente ou desorganisee
FR2855968B1 (fr) 2003-06-13 2012-11-30 Coletica Stimulation de la synthese et de l'activite d'une isoforme de la lysyl oxydase-like loxl pour stimuler la formation de fibres elastiques
US8226715B2 (en) 2003-06-30 2012-07-24 Depuy Mitek, Inc. Scaffold for connective tissue repair
CA2562871C (en) 2004-02-20 2014-06-10 Human Matrix Sciences, Llc Iron based compounds for elastogenesis and connective tissue treatment
US7192043B1 (en) 2004-05-25 2007-03-20 Mcluen Design, Inc. Multi-terrain wheel chair
US7968085B2 (en) 2004-07-05 2011-06-28 Ascendis Pharma A/S Hydrogel formulations
US20060062768A1 (en) 2004-09-23 2006-03-23 Olexander Hnojewyj Biocompatible hydrogel compositions
WO2006098024A1 (ja) 2005-03-16 2006-09-21 Fujitsu Limited Ipネットワークにおけるマルチキャストツリー監視方法およびシステム
US20100233783A1 (en) 2005-03-24 2010-09-16 Straumann Holding Ag Novel method for protein purification
US8828433B2 (en) 2005-04-19 2014-09-09 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
KR100785378B1 (ko) 2005-09-05 2007-12-14 주식회사 바이오레인 다층구조의 유착방지제
WO2007048115A2 (en) 2005-10-19 2007-04-26 Gregory Kenton W Method of using and producing tropoelastin and tropoelastin biomaterials
US7770126B2 (en) 2006-02-10 2010-08-03 Microsoft Corporation Assisting user interface element use
US8518105B2 (en) 2006-03-24 2013-08-27 Abbott Cardiovascular System Inc. Methods and apparatuses for coating a lesion
US20070237735A1 (en) 2006-03-31 2007-10-11 Laboratoires Dermo-Cosmetik Inc. Anti-aging composition, kit and method of use
US8075920B2 (en) * 2006-05-11 2011-12-13 Regenics A/S Administration of cells and cellular extracts for rejuvenation
US20070287741A1 (en) 2006-06-13 2007-12-13 Uri Herzberg Compositions and methods for preventing or reducing postoperative ileus and gastric stasis in mammals
WO2008033847A2 (en) 2006-09-11 2008-03-20 Emory University Modified protein polymers
US7700126B2 (en) 2006-09-29 2010-04-20 Martin Kean Chong Ng Tropoelastin-based protoelastin biomaterials
US8101717B2 (en) * 2006-11-13 2012-01-24 The University Of Sydney Use of tropoelastin for repair or restoration of tissue
WO2009015372A1 (en) * 2007-07-25 2009-01-29 Dermaplus, Inc. Photo-protective dermatological formulations and methods of using the same
US8455459B2 (en) 2007-08-02 2013-06-04 Medicis Pharmaceutical Corporation Method of applying an injectable filler
FR2920968B1 (fr) 2007-09-14 2009-11-13 Oreal Procede cosmetique de traitement esthetique et/ou reparateur de la peau
WO2009099570A2 (en) 2008-02-01 2009-08-13 Wake Forest University Health Sciences Aligned scaffolding system for skeletal muscle regeneration
US8469961B2 (en) 2008-03-05 2013-06-25 Neville Alleyne Methods and compositions for minimally invasive capsular augmentation of canine coxofemoral joints
US8940331B2 (en) 2008-11-22 2015-01-27 The Board Of Trustees Of The Leland Stanford Junior University Hydrogels, methods of making hydrogels, methods of using hydrogels, and methods of isolating, trapping, attracting, and/or killing cancer cells
US8080265B2 (en) 2009-02-20 2011-12-20 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating signs of skin aging
CN102348464B (zh) * 2009-03-10 2016-05-25 悉尼大学 可注射生物材料
AU2011229730B2 (en) 2010-03-22 2016-01-07 Allergan, Inc. Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
WO2011127478A1 (en) 2010-04-09 2011-10-13 Nanovasc, Inc. Sleeve for graft and method
US8658711B2 (en) 2010-09-29 2014-02-25 Rutgers, The State University Of New Jersey Process for the synthesis of methacrylate-derivatized type-1 collagen and derivatives thereof
WO2012068619A1 (en) 2010-11-23 2012-05-31 Elastagen Pty Ltd Preparation and/or formulation of proteins cross-linked with polysaccharides
GB201021438D0 (en) 2010-12-16 2011-02-02 Imp Innovations Ltd Layered fibrous construct
US9114128B2 (en) * 2011-09-30 2015-08-25 Protein Genomics, Inc. Tropoelastins and uses thereof
ES2729285T3 (es) 2011-09-30 2019-10-31 Allergan Pharmaceuticals Int Ltd Síntesis in vivo de fibra elástica
WO2014063194A1 (en) * 2012-10-23 2014-05-01 The University Of Sydney Elastic hydrogel
EP3821918A1 (en) 2012-12-10 2021-05-19 Allergan Pharmaceuticals International Limited Scalable three-dimensional elastic construct manufacturing
CN110464837A (zh) * 2013-08-13 2019-11-19 爱力根制药国际有限公司 受损组织的再生
CN106068272B (zh) 2013-09-24 2021-08-03 爱力根制药国际有限公司 提取蛋白质的方法

Also Published As

Publication number Publication date
JP2016527979A (ja) 2016-09-15
MX2020011880A (es) 2021-01-20
EP4316537A3 (en) 2024-04-10
AU2014306362B2 (en) 2019-04-18
CN110464837A (zh) 2019-11-19
AU2021245202A1 (en) 2021-11-04
RU2677637C2 (ru) 2019-01-18
BR112016003082A8 (pt) 2020-01-28
JP2018164789A (ja) 2018-10-25
JP6891257B2 (ja) 2021-06-18
KR20160041949A (ko) 2016-04-18
KR20210154881A (ko) 2021-12-21
KR20230004965A (ko) 2023-01-06
WO2015021508A1 (en) 2015-02-19
EP4316537A2 (en) 2024-02-07
EP3033099A1 (en) 2016-06-22
US20220098281A1 (en) 2022-03-31
AU2014306362A1 (en) 2016-02-18
US11084867B2 (en) 2021-08-10
JP6382311B2 (ja) 2018-08-29
EP3033099A4 (en) 2017-04-12
AU2019204972A1 (en) 2019-08-01
JP2020049282A (ja) 2020-04-02
CA2920312A1 (en) 2015-02-19
JP6639587B2 (ja) 2020-02-05
US20160194379A1 (en) 2016-07-07
CN105530951A (zh) 2016-04-27
RU2016104618A (ru) 2017-09-14
BR112016003082A2 (pt) 2017-08-01
EP3033099B1 (en) 2023-11-01
CA2920312C (en) 2022-07-19
CN105530951B (zh) 2019-10-22
RU2016104618A3 (es) 2018-06-18
KR102488446B1 (ko) 2023-01-13
US20190062405A1 (en) 2019-02-28
AU2019204972B2 (en) 2021-07-08
ES2965893T3 (es) 2024-04-17

Similar Documents

Publication Publication Date Title
MX2020011880A (es) Regeneracion de tejido da?ado.
HK1224223A1 (zh) 包含膠原蛋白肽、彈性蛋白肽及蛋白多糖的組合物
IL239754A0 (en) A power source and controller for operating an implantable blood pump
HK1220097A1 (zh) 組織結紮裝置及其方法
MX2016005157A (es) Dispositivo de cierre de herida con presion negativa.
EP2988676A4 (en) Tissue resecting systems and methods
HK1220886A1 (zh) 組織結紮裝置及其方法
HK1222586A1 (zh) 傷口癒合與組織工程
EP3046522A4 (en) Wound dressing containing polysaccharide and collagen
EP3033338A4 (en) Selective grp94 inhibitors and uses thereof
BR302013006822S1 (pt) Configuração aplicada em curativo médico.
EP3067105A4 (en) Ballast water treatment device
HK1215540A1 (zh) 用於治療或預防疾病的因子 蛋白、因子 蛋白及其抑制劑
EP3065631A4 (en) Noninvasive predictive and/or estimative blood pressure monitoring
MX359181B (es) Hidrolizado de colágeno y uso del mismo.
EP2986308A4 (en) Angiotensin ii alone or in combination for the treatment of hypotension
EP3043446A4 (en) Discharge start time determination system for electricity storage device and discharge start time determination method for electricity storage device
EP3559253A4 (en) BLOOD PROFILING WITH PROTEASE INHIBITORS
PL3044229T3 (pl) Peptydy do zastosowania w leczeniu zapalenia błony śluzowej jamy ustnej
MX358845B (es) Combinacion sinergica de alanina-glutamina, acido hialuronico y un extracto de avena y su uso en una composicion destinada para la curacion de heridas y reparacion de lesiones de la piel.
PL3137102T3 (pl) Apc do stosowania w leczeniu nieprawidłowego bliznowacenia skóry
EP2964332A4 (en) NEURAL REGENERATION PEPTIDES AND USES THEREOF
HK1223631A1 (zh) 預防和治療炎症的小分子多肽及其應用
EP3010579A4 (en) Treating skin ulcers
GB201307967D0 (en) Therapeutic agents for modulating thymic function and/or growth

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED

FG Grant or registration